Combination Immunotherapy

Combination Immunotherapy is a therapeutic strategy within cancer immunology and immuno-oncology pharmacotherapy that integrates two or more distinct immunotherapeutic agents or modalities to enhance anti-tumor immune responses through complementary or synergistic mechanisms.

7.1K

Publications

547.3K

Citations

48.8K

Authors

6.1K

Institutions

Publications per year

2017–2026

4.3K

Authors

48.8K

  1. FS
    F. Stephen Hodi

    Dana-Farber Cancer Institute, United States

    87 publications · 39K citations

    48

    h-index

  2. GV
    Georgina V. Long

    The University of Sydney, Australia

    85 publications · 29.8K citations

    45

    h-index

  3. JD
    Jedd D. Wolchok

    Memorial Sloan Kettering Cancer Center, United States

    73 publications · 41.7K citations

    44

    h-index

  4. PA
    Paolo A. Ascierto

    Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Italy

    97 publications · 32.6K citations

    43

    h-index

  5. DS
    Dirk Schadendorf

    Heidelberg University, Germany

    57 publications · 25.1K citations

    35

    h-index

1–5 of 48.8K

Venues

  1. Journal of Clinical Oncology

    725 publications · 50.8K citations

    109

    h-index

  2. Clinical Cancer Research

    267 publications · 33.1K citations

    98

    h-index

  3. Journal for ImmunoTherapy of Cancer

    JITC · 308 publications · 20.4K citations

    75

    h-index

  4. PubMed

    Repository · 387 publications · 18K citations

    69

    h-index

  5. Cancer Research

    148 publications · 15.8K citations

    64

    h-index

1–5